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Abstract
Drosophila is a well recognized model of several human diseases, and recent investigations have demonstrated that
Drosophila can be used as a model of human heart failure. Previously, we described that optical coherence tomography
(OCT) can be used to rapidly examine the cardiac function in adult, awake flies. This technique provides images that are
similar to echocardiography in humans, and therefore we postulated that this approach could be combined with the vast
resources that are available in the fly community to identify new mutants that have abnormal heart function, a hallmark of
certain cardiovascular diseases. Using OCT to examine the cardiac function in adult Drosophila from a set of molecularly-
defined genomic deficiencies from the DrosDel and Exelixis collections, we identified an abnormally enlarged cardiac
chamber in a series of deficiency mutants spanning the rhomboid 3 locus. Rhomboid 3 is a member of a highly conserved
family of intramembrane serine proteases and processes Spitz, an epidermal growth factor (EGF)–like ligand. Using multiple
approaches based on the examination of deficiency stocks, a series of mutants in the rhomboid-Spitz–EGF receptor
pathway, and cardiac-specific transgenic rescue or dominant-negative repression of EGFR, we demonstrate that rhomboid 3
mediated activation of the EGF receptor pathway is necessary for proper adult cardiac function. The importance of EGF
receptor signaling in the adult Drosophila heart underscores the concept that evolutionarily conserved signaling
mechanisms are required to maintain normal myocardial function. Interestingly, prior work showing the inhibition of ErbB2,
a member of the EGF receptor family, in transgenic knock-out mice or individuals that received herceptin chemotherapy is
associated with the development of dilated cardiomyopathy. Our results, in conjunction with the demonstration that
altered ErbB2 signaling underlies certain forms of mammalian cardiomyopathy, suggest that an evolutionarily conserved
signaling mechanism may be necessary to maintain post-developmental cardiac function.
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Introduction
The identification of genes that cause or modify cardiac
dysfunction is required to understand the complex biology that
is responsible for cardiomyopathies and heart failure in humans.
The screening and identification of genetic mutants that affect
cardiac function are facilitated by model systems of human heart
failure. Drosophila has been used as a model of several human
diseases and recent investigations have demonstrated that
Drosophila can be used as a model of human heart failure, defined
as an abnormally enlarged cardiac chamber when the heart is fully
relaxed at end-diastole and an impaired systolic function [1–5].
Previously, we described that optical coherence tomography
(OCT) can be used to examine the cardiac function in adult,
awake flies [5]. OCT is a non-destructive, non-invasive imaging
modality based on reflectivity of near-infrared light and provides
detailed functional imaging of the adult fly heart in a manner
similar to echocardiography in humans.
To identify new gene mutations that cause an enlarged cardiac
chamber, we employed OCT to examine the cardiac chamber size
in adult Drosophila from a set of the DrosDel and Exelixis
collections that have molecularly-defined genomic deficiencies
[6,7]. During the course of our genetic screen, we identified
abnormalities in cardiac chamber dimensions in a series of
deficiency mutants spanning the rhomboid 3 locus. Drosophila
rhomboid 3 (rho3), also known as roughoid/ru, is a member of a highly
conserved family of intramembrane serine proteases and processes
Spitz, an epidermal growth factor (EGF)-like ligand [8–14].
Initially, isolated in a genetic screen of embryonic developmental
defects, rhomboids are essential for proper EGF receptor (EGFR)
signaling in Drosophila. In fact, rhomboid and EGFR signaling is
necessary for the development of the fly eye, trachea, and
embryonic somatic musculature and many other places in the fly
[7,8,15–17].
Spitz and EGFR signaling are required for the specification and
diversification of Drosophila embryonic muscle progenitors [16].
During development, individual muscle groups are differentially
sensitive to the level of EGFR signaling that results from the spatial
restriction of Spitz and other ligands [14]. Rhomboids have been
implicated in this process and rhomboid-1 (rho) has been shown to
be required for dorsal acute 1 (DA1) muscle formation in the
embryo [16].
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develops through an orchestrated series of spatially restricted
mesodermal and ectodermal signals involving dpp, Wnt, and
hedgehog [18–22]. During morphogenesis the adult heart, also
known as the conical chamber, arises from the embryonic aorta
while the embryonic dorsal vessel degenerates to become the
terminal chamber of the adult circulatory system [23,24].
Recently, Perrin et al. have begun to elucidate the signaling
pathways in the transition from the fly embryonic to adult heart
through an examination of gene profiling studies [25]. This work
has identified roles for FGF, Wnt, and PDGF-VEGF signaling in
the morphogenesis of the adult fly heart. However, the signaling
pathways that are necessary for maintenance of cardiac function
after establishment of the adult Drosophila circulatory system are
only recently beginning to be identified [2,26].
Our results demonstrate that a partial inhibition of rho3 causes
an enlargement in the cardiac chamber in adult Drosophila through
inhibition of the EGFR pathway. We show that the mutant
roughoid-1, designated ru
1, encodes a missense mutation in rho3
corresponding to a premature stop codon and has a recessive
cardiac phenotype. While the ru
1 homozygote embryonic dorsal
vessel and pupal heart are not significantly different from w
1118,
the adult heart in ru
1 homozygote is larger than w
1118, consistent
with the functional measurements obtained by OCT. Further-
more, the restoration of rho3 by cardiac expression of transgenic
wild-type rho3 rescues cardiac function in the context of genomic
deficiencies for endogenous rho3 or the ru
1 mutant.
Since rho3 is important in processing of Spitz and subsequent
EGFR signaling, we examined the effects of alteration in Spitz and
EGFR on cardiac function in adult Drosophila. Cardiac specific
expression of a processed form of activated Spitz rescued the
abnormality in cardiac phenotype that was observed in rho3
mutants. Additionally, expression of EGFR also restores cardiac
function in the context of genomic deficiencies in rho3 or the ru
1
mutant. Finally, a temperature-sensitive, cardiac specific expres-
sion of dominant-negative EGFR in adult Drosophila causes a
progressive enlargement of the cardiac chamber that is observed
by serial OCT measurements. Collectively, these results suggest
that deficiencies in rho3 and its downstream components in the
EGFR signaling pathway lead to an enlargement of the cardiac
chamber in adult Drosophila.
Results
Identification of a genomic deficiency on chromosome
3L that is associated with an enlarged cardiac chamber
As part of a systematic, genome wide screen in Drosophila to
identify candidate gene mutations that cause abnormalities in
adult cardiac function, we employed optical coherence tomogra-
phy to examine the cardiac function in awake, adult Drosophila [5].
We examined flies with molecularly-defined genomic deficiencies
along the 3L chromosome from the DrosDel and Exelixis
collections and identified a set of mutants that had a dilated heart
manifest as enlarged end-diastolic dimension (EDD) and end-
systolic dimension (ESD). We also calculated fractional shortening
(FS), a parameter that correlates with contractile function and has
been used to describe the cardiac function in a variety of models of
cardiovascular disease [27–32] (Figure S1). All deficiency mutants
were bred into a w
1118 background to remove possible influences
that balancer chromosomes may have on the cardiac phenotype.
Therefore, all the genomic deficiency mutants were examined as
heterozygotes. In an initial screen of 32 deficiency stocks (Table
S1), we identified a markedly enlarged cardiac chamber in mutant
Df(3L)ED4238/+ (Figure 1A–1D). The severity of the cardiac
chamber enlargement observed in Df(3L)ED4238/+ was indistin-
guishable from the cardiac dysfunction in the troponin-I mutant,
hdp
2, that has been previously well-characterized [5]. An
examination of the cardiac chamber size in deficiency mutants
that surrounded the region corresponding to Df(3L)ED4238/+
revealed three additional genomic deficiencies, Df(3L)ED4196/+,
Df(3L)ED207/+, and Df(3L)ED4191/+, that had abnormal
cardiac dimensions thereby narrowing the initial genomic interval
from ,800Kb to a candidate region encompassing ,120 Kb that
encoded 9 genes (Figure 2 and Table 1). Since the resolution of
OCT is limited to 8 microns, we also examined the data in a
dichotomized manner. We defined ‘‘normal’’ diastolic cardiac size
as an EDD ,90 microns and an ‘‘enlarged heart’’ as an EDD .
90 microns. Additionally, ‘‘normal’’ systolic cardiac dimension was
defined as ,20 microns and ‘‘abnormal’’ systolic dimension as .
20 microns. The examination of dichotomized data also supported
the observation that Df(3L)4238/+, Df(3L)ED4196/+,
Df(3L)ED207/+, and Df(3L)ED4191/+ had abnormal cardiac
chamber sizes.
To identify the candidate gene that was responsible for the
abnormal cardiac phenotype within the region, mutants from the
Exelixis P-element insertion collection were used to engineer
mutant Drosophila that had molecularly-defined deficiencies
spanning the genomic region of interest [6]. The deficiency
mutant, f05423-d04958/+, spanned the genomic region that was
inferred from the initial screen and had an enlarged cardiac
chamber compared to w
1118 (EDD 102 +/- 7 microns and ESD
27 +/- 6 microns for f05423-d04958/+ versus EDD of 66 +/- 8
microns, and ESD of ,10 microns for w
1118) (Table 1).
Interestingly, a smaller genomic deficiency, designated d07829-
f07223/+, that encompassed the gene encoding rhomboid 3,
(herein referred to as rho3) and CG32320 also demonstrated an
enlarged cardiac chamber (EDD 105 +/- 9 microns and ESD 35
+/- 7 microns for d07829-f07223/+) while a genomic deficiency,
f05432-d01050/+, encoding several genes upstream of rho3 had
normal cardiac function (Figure 2 and Table 1). rho3 mRNA
levels were significantly decreased (,25% in d07829-f07223/+
compared to w
1118), while no different in f05432-d01050/+
Author Summary
Heart failure is a common cardiovascular disease that is
characterized by problems with the ability of the heart
muscle to contract, called impaired systolic function, and
an enlarged heart chamber. Model systems of human
heart failure are necessary to facilitate the screening and
identification of genes and genetic variations that either
cause or influence the development and progression of
this disease. To better understand these genes, we
conducted a genetic screen employing molecularly
defined deletions throughout the genome of the adult
fruit fly, Drosophila melanogaster. We used an optical
coherence tomography imaging technique that provided
images similar to echocardiography in humans to measure
the cardiac function in adult flies. We identified mutants in
members of the rhomboid protease family and epidermal
growth factor receptor that cause an enlarged cardiac
chamber. Interestingly, abnormalities in the function of
members of the epidermal growth factor receptor family in
humans that undergo certain chemotherapies are associ-
ated with the development of dilated cardiomyopathy and
heart failure. Our results suggest that epidermal growth
factor receptor signaling may be an evolutionarily
conserved pathway that is necessary to maintain normal
adult cardiac function.
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(Figure 3B). Furthermore, we observed normal cardiac function
in the mutant Df(3L)Exel6087/+ that was heterozygous for a
deficiency across the rho1 and rho2 loci but did not disrupt rho3
(Table 1). Since the candidate region also contained the predicted
gene CG32320, we examine the cardiac phenotype in two
mutants that had the insertion of P-elements into the GC32320
genomic regions. Mi{Et1}CG32320
MB04181, inserted into the
coding region of the 4th predicted exon of CG32320, and
Mi{ET1}CG32320
MB08823, inserted in the 59 UTR region of
CG32320, had normal cardiac phenotypes (Table 1). Based on
these observations, we focused our attention on rho3 as the
candidate gene that was responsible for the abnormal cardiac
phenotype observed in the deficiency mutants.
The mutant ru
1 encodes a missense mutation in rho3 and
has an enlarged cardiac chamber
Next, we examined available mutants that spanned the
candidate region and identified a cardiac abnormality in roughoid
(ru
1). ru
1 was initially isolated by Sturtevant in 1918, has been
shown to be a hypomorphic allele that results in a rough eye
phenotype, and was subsequently mapped to the rho3 locus
[13,33]. The ru
1 mutant had a C to T mutation at cDNA
nucleotide position 163 that predicted a premature stop codon in
rho3 at amino acid position 55 (Figure S2); however, expression of
recombinant Flag-tag fusion protein from cDNA isolated from ru
1
flies did not encode a truncated protein in S2 cells (Figure S2).
Only homozygote ru
1 mutant flies had enlarged cardiac phenotype
(EDD 107 +/2 3 microns and ESD 47 +/2 2microns (n=12) for
Figure 1. Identification of a genomic deletion mutant that has an enlarged cardiac chamber. (A,B) Representative B-mode optical
coherence tomography (OCT) images of w
1118 (A) and Df(3L)ED4238/+ (B) during diastole and systole in longitudinal and transverse orientations. The
red arrows denote the cardiac chamber. A 125 micron standard is shown. (C) Representative m-mode OCT images of w
1118, Df(3L)ED4238/+, and hdp
2.
The position of end-diastolic dimension (EDD) and end-systolic dimension (ESD) during the cardiac cycle are indicated by red arrows. Each m-mode
represents one second and a 125 micron standard is shown. (D) Summary data of cardiac measurements for end-diastolic dimension (EDD) and end-
systolic dimension (ESD) from w
1118, Df(3L)ED4238/+, and hdp
2. Closed circles represent individual measurements for each group, open circles
represent the mean 6 SEM for each group. n=13217 flies per group. *p,0.05 for the indicated measurements compared to w
1118 using an ANOVA
with Bonferroni correction for multiple comparisons for EDD or Kruskal-Wallis test with a Dunn’s test for multiple comparisons for ESD.
doi:10.1371/journal.pgen.1000969.g001
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PLoS Genetics | www.plosgenetics.org 3 May 2010 | Volume 6 | Issue 5 | e1000969Figure 2. Schematic representation of the candidate region of chromosome 3L. Each line represents the region of the genome that is
deleted in gray with the DrosDel or Exelixis stock designation to the left of the line. Representative OCT m-modes corresponding to each strain are
shown to the right. A 125 micron standard is shown. Inclusion of regions that correspond to dilated cardiac phenotype and exclusion of regions that
had normal cardiac function is represented by the red lines and narrows the interval to ,122 kb of genomic DNA. The genes encoded within the
candidate region are shown below with ru (rho3) represented in black. The d07829-f07223/+ and f05432-d01050/+ custom genomic deletions with
representative OCT m-modes are shown below.
doi:10.1371/journal.pgen.1000969.g002
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1 mutants versus EDD 81 +/2 5 microns and ESD
,10 microns (n=12) for heterozygote ru
1 mutants) (Figure 3A).
The abnormal recessive cardiac phenotype persisted after several
rounds of backcrossing into the w
1118 genetic background (data not
shown).
Interestingly, the initial identification of an enlarged cardiac
chamber was made in heterozygous genomic deficiency mutants;
however, abnormalities in cardiac chamber size were only found
in homozygous ru
1 mutants. This observation is consistent with
prior studies that identified ru1 as a hypomorphic allele based on
abnormalities in fly eye phenotypes [13]. We also examined the
cardiac chamber size in rho-3
PLLb, a mutant that has a break in the
first intron of rhomboid-3 and removes a portion of the rhomboid-3
coding sequence [13]. The rho-3
PLLb allele has been described as a
null allele, and therefore should lead, when heterozygous, to the
same phenotype as the heterozygous genomic deficiencies
Df(3L)ED4328/+. We used QRT-PCR to confirm that heterozy-
gotes for rho-3
PLLb had a 50% reduction in rho3 mRNA, similar to
rho3 mRNA levels in heterozygous Df(3L)ED4238/+, while
homozygotes for rho-3
PLLb had non-detectable levels of rho3
mRNA (Figure 3B). Mutants homozygous or heterozygous for
the rho-3
PLLb allele had enlarged cardiac chambers (Figure 3A and
Table 2). The ESD in mutants for homozygous rho-3
PLLb was
slightly larger than that for heterozygous rho-3
PLLb but did not
achieve statistical significance.
Additionally, we examined the contribution of rho4 and rho6
abnormalities on cardiac function using mutants that were
deficient for rho4, rho6 or both rho4 and rho6 (Freeman, M.
unpublished data). Mutants that lacked rho4, rho6 or both rho4
and rho6 had normal cardiac function (Table 2). We also
examined the potential contribution of rho1 and rho3 by
examining the cardiac function in ru
1/+, rho
7M43/+ flies that were
heterozygous for the rho3/ru allele and an amorphic allele of rho1.
The ru
1/+, rho
7M43/+ mutants had normal cardiac function
(Table 2), suggesting that cardiac abnormalities observed in the
homozygous ru
1 mutants were not phenocopied by a combination
of defects in rho3 and rho1. These data suggested that rho-3
inactivation is responsible for the observed enlarged heart
phenotype; however, we could not definitely rule out the
contribution from rho-1.
The enlarged cardiac chamber in mutant ru
1 does not
result from a developmental defect
Rhomboid-3 is expressed in embryos, pupae, and adult tissues
including the heart (Table S2). Since alterations in embryonic
dorsal vessel development can lead to abnormal cardiac
phenotypes in adult Drosophila, the dorsal vessel morphology was
evaluated in Drosophila embryos from stage 13 to 16. Transgenic
Drosophila that express tinC-GFP in the context of w
1118 or ru
1
homozygotes demonstrated similar dorsal vessel morphology (data
not shown). The heart in transgenic Drosophila that expressed tinC-
GFP in the context of w
1118 or ru
1 homozygotes did not show a
significant difference in overall morphology at different stages of
pupal development (Figure S3).
Since adult homozygous ru
1 mutants had an enlarged cardiac
chamber by OCT, the morphology of the adult cardiac chamber
in ru
1 homozygous mutants was evaluated by histological
sectioning. A comparison between w
1118 and ru
1 homozygous
mutants was performed by examining 8 micron serial sections in
the posterior portion of the A1 segment (see details in Materials
and Methods section). Although the cardiac chamber size in ru
1
was larger than w
1118, consistent with OCT results, and the
cardiac chamber wall thickness in ru
1 homozygote mutants
Table 1. Summary of cardiac parameters of adult Drosophila that have genomic deficiencies along 3L.
N
EDD ± SEM
(microns)
ESD ± SEM
(microns) FS ± SEM (%)
Dilated (EDD.90
microns)
Impaired systolic
function (ESD.20
microns)
W
1118 17 6668 ,10 .85 N N
Df(3L)ED4177/+ 88 3 66 ,10 .88 N N
Df(3L)ED202/+ 10 7562 ,10 .87 N N
Df(3L)Exel6085/+ 12 6565 ,10 .85 N N
Df(3L)Exel6086/+ 87 8 65 ,10 .88 N N
Df(3L)ED4191/+ 81 0 6 64* 4363* 5963Y Y
Df(3L)ED4196/+ 10 12164* 5565* 5563Y Y
Df(3L)ED4238/+ 13 10364* 3764* 6462Y Y
Df(3L)ED207/+ 17 10964* 4963* 5563Y Y
Df(3L)Exel6087/+ 12 7765 ,10 .87 N N
f05423-d04958/+ 81 0 2 67* 2766* 7363Y Y
d07829-f07223/+ 15 10569* 3567* 6865Y Y
f05423-d01050/+ 16 8164 ,10 .89 N N
Mi{ET1}CG32320
MB04181/+ 10 80610 ,10 .88 N N
Mi{ET1}CG32320
MB08823/+ 98 0 610 ,10 .88 N N
hdp
2 12 10967* 4365* 6163Y Y
The data represent the cardiac measurements in adult flies obtained by OCT for end-diastolic dimension (EDD) in microns, end-systolic dimension (ESD) in microns, and
fractional shortening (FS). FS was calculated as (EDD-ESD)/EDD6100. Values are expressed as the mean +/- SE. N represents the number of samples per group. *p,0.05
for EDD compared to w
1118 using ANOVA with Bonferroni correction for multiple comparisons or ESD compared to w
1118 using Kruskal-Wallace with Dunn’s correction
for multiple comparisons. Additionally, the data is represented in a binary manner with ‘‘Dilated’’ defined as an EDD . 90 microns and ‘‘Impaired Systolic Function’’
defined as an ESD .20 microns where ‘‘N’’ = no and ‘‘Y’’=yes.
doi:10.1371/journal.pgen.1000969.t001
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1 or rho3
pLLB have enlarged cardiac chambers. (A) Summary data of cardiac measurements
for end-systolic dimension (ESD) (top) and end-diastolic dimension (EDD) (bottom) from w
1118, ru
1 homozygotes (designated ru
1/ru
1), ru
1
heterozygotes (ru
1/+), rho3
pLLB heterozygotes (rho3
pLLB/+), and rho3
pLLB homozygotes (rho3
pLLB/rho3
pLLB). Closed circles represent individual
Rhomboid/EGFR in Adult Drosophila Hearts
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1118, the extra cardiac structures
appeared similar between ru
1 and w
1118 (Figure S4).
Moreover, the actin fibers in the dorsal diaphragm muscle, also
known as the ventral longitudinal fibers, and cardiomyocytes in
adult Drosophila hearts were examined via using confocal
microscopy. Visualization of actin structures by staining with
phalloidin demonstrated that the dorsal diaphragm muscle was
similar between ru
1 homozygotes and w
1118. The GFP positive
cardiomyocyte nuclei and actin fiber organization were also
similar (Figure 4). Overall, the tissue surrounding the adult hearts
in dissected specimens was similar in ru
1 homozygotes and w
1118.
The functional abnormalities observed in the ru
1 homozygous
mutants did not appear to be related to alterations in extra cardiac
structures.
In addition, the other cardiac parameters, such as arrhythmia
and heart rate, were not significantly different between ru
1
homozygotes and w
1118 in intact adults or in dissected adult
hearts perfused with artificial hemolymph (Figure S5).
Cardiac expression of Rho3, Spitz, or EGFR rescues the
abnormal cardiac phenotype in DF(3L)4238/+ and
homozygous ru
1 mutants
To confirm whether rho3 was responsible for the abnormal
cardiac phenotype, we engineered transgenic Drosophila that
harbored wild-type (wt)-rho3 under the UAS-promoter. In
combination with cardiomyocyte specific tinC-Gal4 driver, we
examined the effects of cardiac-specific expression of wt-rho3 in the
context of Df(3L)ED4238/+ or ru
1 homozygotes. The tinC-
mediated expression of wt-rho3 rescued the abnormal enlarged
cardiac phenotype (Figure 5). Furthermore, the enlarged cardiac
chamber phenotype that was observed in other genomic
deficiencies spanning rho3 [Df(3L)ED4191/+ or Df(3L)ED4196/+]
was also rescued by wt-rho3 (data not shown).
Since rho3 is known to process an inactive membrane-bound
Spitz (mSpi) to an active soluble Spitz (sSpi) that can subsequently
interact with EGFR, we examined the effects of these components
on cardiac function in flies that had enlarged cardiac chambers
attributed to genomic deficiencies [10]. The cardiac expression of
sSpi, but not mSpi, rescued the abnormal cardiac phenotype
observed in the Df(3L)ED4238/+ mutant (Figure 5). Furthermore,
the cardiac-specific expression of EGFR in the context
Df(3L)ED4238/+ also restored normal cardiac function. We also
tried to examine the ability of constitutively active forms of EGFR
to rescue the abnormal cardiac phenotype observed in the
genomic deficiency mutants [34,35]. The cardiac-specific expres-
sion of EGFR
Act(2) resulted in a failure of flies to eclose from the late
pupal state (data not shown).
Next, we examined the effects of cardiac-specific expression of
mSpi, sSpi, and EGFR in the context of ru
1 homozygous mutant
[10,36,37]. The cardiac-specific expression of sSpi or EGFR by
tinC-Gal4 in the context of ru
1 homozygotes restored normal
cardiac function while expression of mSpi by tinC-Gal4 in the
context of ru
1 homozygotes still had an enlarged cardiac chamber
(Figure 5).
Additionally, we examined spi
1, a loss of function allele, and
spi
s3547, a P-element insertion mutant. Both mutants are lethal as
homozygotes and therefore were examined in the heterozygous
state [38]. spi
1/+ and spi
s3547/+ had normal cardiac function
(Table 2). Interestingly, spi-SCP2, a homozygous viable hypo-
morph of Spi, had an abnormal cardiac phenotype (Table 2).
Moreover, the homozygous mutant Keren
exc27-7-B that lacks Keren,
measurements for each group, open circles represent the mean 6 SEM for each group. n=8217 flies per group. *p,0.05 for the indicated
measurements by ANOVA with Bonferroni correction for multiple comparisons for EDD or Kruskal-Wallis test with a Dunn’s test for multiple
comparisons for ESD. (B) Summary data for expression of mRNA for rho1 or rho3 in w
1118, Df(3L)ED4238/+, heterozygous genomic deficiencies d07829-
f07223/+ or f05432-d01050/+, ru
1 homozygous mutants (ru
1/ru
1), rho3
pLLB heterozygotes (rho3
pLLB/+), or rho3
pLLB homozygotes (rho3
pLLB/rho3
pLLB).
Values are expressed as the mean mRNA expression +/- SEM relative to w
1118 and represent three independent experiments using 10 flies per group
per experiment. Rho3 mRNA was not detected (N.D.) in rho3
pLLB homozygotes. *p,0.05 for rho3 in Df(3L)ED4328/+, d07829-f07223/+,o rrho3
pLLB/+
versus w
1118 by t-test.
doi:10.1371/journal.pgen.1000969.g003
Table 2. Summary of cardiac parameters of adult Drosophila with mutations in Rhomboids, Spitz, or Keren.
N
EDD ± SEM
(microns)
ESD ± SEM
(microns) FS ± SEM (%)
Dilated (EDD.90
microns)
Impaired systolic
function (ESD.20
microns)
ru
1/+;r h o
7M43/+ 12 7763 ,10 .87 N N
rho3
pLLB/rho3
pLLB 12 113644 6 635 9 63Y Y
rho3
pLLB/+ 12 105633 8 646 5 63Y Y
rho 4-D ˜/rho 4-D 11 7563 ,10 .87 N N
rho 6 null/rho 6 null 77 8 63 ,10 .87 N N
rho 4-D/rho 4-D;r h o6
null/rho 6 null
11 8164 ,10 .88 N N
spi
1/+ 98 2 63 ,10 .88 N N
spi
s3547/+ 10 7865 ,10 .87 N N
spi-SPC2/spi-SPC2 11 114643 6 656 7 64Y Y
Keren
exc27-7-B/Keren
exc27-7-B 11 7363 ,10 .86 N N
The data represent the cardiac measurements in adult flies obtained by OCT for end-diastolic dimension (EDD) in microns, end-systolic dimension (ESD) in microns, and
fractional shortening (FS). FS was calculated as (EDD-ESD)/EDD 6100. Values are expressed as the mean +/- SE. N represents the number of samples per group.
Additionally, the data is represented in a binary manner with ‘‘Dilated’’ defined as an EDD .90 microns and ‘‘Impaired Systolic Function’’ defined as an ESD .20 microns
where ‘‘N’’ = no and ‘‘Y’’=yes.
doi:10.1371/journal.pgen.1000969.t002
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cells in the Drosophila ovary had normal cardiac function
[15,39,40] (Table 2).
These results suggest that the enlarged cardiac phenotypes
observed in Df(3L)ED4238/+ and ru
1 homozygotes result from
alterations in EGFR signaling since the abnormal cardiac
Figure 4. Evaluation of the A2 cardiac segment in homozygous ru
1 mutants. Panels are representative Z-stack confocal microscopy images
of the A2 segment of adult hearts from w
1118 (A-C) and homozygous ru
1 mutants (D-F). Antibody staining of GFP (A and D) shows tinC positive
cardiomyocytes and nuclei in monochrome. Texas-red phalloidin staining (B and E) shows actin structures in the cardiomyocytes and the extra
cardiac (non-tinC positive) dorsal diaphragm muscle in monochrome. Merged imaged (C and F) show overlays of GFP (green) and actin (red) staining.
doi:10.1371/journal.pgen.1000969.g004
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soluble Spi. Furthermore, Spi may have a threshold effect on
cardiac function since heterozygote loss of function alleles for Spi
had a normal cardiac phenotype; but, the homozygous
hypomorph, spi-SCP2, had an abnormal cardiac function
[15,38] (Table 2).
Cardiac expression of dominant-negative EGFR causes
post-developmental dilated cardiac chamber in adult
Drosophila
Since restoration of EGFR signaling by transgenic expression of
sSpi or EGFR rescued the abnormal cardiac phenotypes observed
in rho3 deficiencies and the ru
1 homozygotes, the effects of
inhibiting EGFR signaling in the adult Drosophila heart were
evaluated using a well-characterized dominant-negative EGFR
(EGFR.DN) [16].
The cardiac function in flies with the hypomorphic allele,
EGFR
24f, in the context of a temperature sensitive lethal allele of
EGFR (EGFR
tsla) was evaluated by performing serial OCT cardiac
measurements in individual flies at 18uC followed by 24 hours at
25uC [37]. Interestingly, the cardiac function in EGFR
f24/tsla flies
was similar to w
1118 at 18uC; however, the cardiac function
deteriorated after 24 hr at 25uC (Figure 6A and 6C).
Next, the cardiac function was assessed by serial OCT
measurements in individual flies that harbored UAS-EGFR.DN,
tubulin-Gal80
ts, and tinC-Gal4 [41–43]. Since the measurement of
cardiac function by OCT is non-invasive and non-destructive, we
serially measured the cardiac function in individual flies by
performing OCT, allowing the fly to recover over a 24 hour
period, and then repeating OCT assessments throughout the
course of the experiments. Prior work in our laboratory
demonstrated that the tubulin-Gal80
ts; tinC-Gal4 fly driver line
Figure 5. Cardiac expression of wt-rho3, soluble Spitz, or EGFR rescues the abnormal cardiac phenotype in Df(3L)ED4238/+ or
homozygous ru
1 mutants. Summary data of cardiac measurements for end-systolic dimension (ESD) (top) and end-diastolic dimension (EDD)
(bottom) from w
1118, homozygous ru
1 mutants (ru
1/ru
1), Df(3L)ED4238/+, and transgenic flies harboring the driver tinC-Gal4 and UAS-wt-rho3, UAS-
mSpi, UAS-sSpi, or UAS-EGFR in the context of the Df(3L)ED4238/+ or the homozygous ru
1 mutant. Closed circles represent individual measurements
for each group, open circles represent the mean 6 SEM for each group. n=8217 flies per group. n=8217 flies per group. *p,0.05 for the indicated
measurements comparing Df(3L)ED4238/+ alone versus Df(3L)ED4238/+ expressing the indicated transgenes. Dp,0.05 for the indicated
measurements comparing homozygous ru
1 alone versus homozygous ru
1 in the context of the indicated transgene. EDD measurements were
analyzed by student’s t-test and ESD measurements were analyzed by Mann-Whitney tests.
doi:10.1371/journal.pgen.1000969.g005
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between a 20 and 40 fold expression of transgene mRNA
expression at 25uC by 24 to 48 hours [44]. Serial OCT cardiac
evaluation in individual flies demonstrated that cardiac function
was normal at 18uC but progressively deteriorated at 25uCa s
manifest by enlarged EDD and ESD (EDD 68 +/- 3 microns and
ESD ,10 microns (n=15) at 18uC verses EDD 118 +/- 4 microns
and ESD 51 +/- 2 microns (n=15) at 25uC for 144 hr for P{UAS-
EGFR.DN}/P{tubulin-Gal80
ts}; P{UAS-EGFR.DN}/P{tinC-
Gal4}) (Figure 6B and 6C). The effects of EGFR.DN expression
on cardiac chamber size were similar in flies of 7 or 30 days age
(data not shown). Interestingly, the EGFR.DN mediated effects on
cardiac chamber size were reversible when the EGFR.DN
expression was repressed by temperature shift (Figure 6B and
6C). The changes observed in cardiac chamber size and function
depended on the expression of specific transgenes since flies that
harbor tubulin-Gal80
ts; tinC-Gal4 in the absence of UAS-
EGFR.DN did not have abnormal cardiac phenotypes under
similar temperature conditions (Figure 6C). Furthermore, flies that
express unrelated UAS transgenes do not demonstrate alterations
under similar temperature shift conditions [2,44]. These results
suggest that inhibition of EGFR signaling in the adult fly heart
Figure 6. Cardiac expression of dominant negative EGFR (EGFR.DN) causes a progressive post-developmental enlarged heart and
impaired systolic function in adult Drosophila. (A) Representative m-mode OCT images for EGFR
f24/tsla at 18uC (baseline) and 24 hours after
temperature shift to 25uC. Horizontal bar represents one second, 125 micron standard is shown. (B) Representative m-mode OCT images for p{UAS-
EGFR.DN}/p{tub-Gal80
ts}; p{UAS-EGFR.DN}/p{tinC-Gal4}, at 18uC (baseline) and 144 hours after temperature shift to 25uCo r2 5 uC (baseline) and 144
hours after temperature shift to 18uC. OCT m-modes are from the same fly obtained at the indicated temperature and time intervals. Horizontal bar
represents one second, 125 micron standard is shown. (C) Summary OCT data for end-diastolic dimension (EDD) (top) and end-systolic dimension
(ESD) (bottom) for EGFR
f24/tsla maintained at 18uC and after 24 hours at 25uC and p{UAS-EGFR.DN}/p{tubulin-Gal80
ts}; p{UAS-EGFR.DN}/p{tinC-Gal4}
maintained at 18uC followed by 24 hour, 96 hours, and 144 hours at 25uC. The summary also shows data for the reversal of the cardiac phenotype for
p{UAS-EGFR.DN}/p{tubulin-Gal80
ts}; p{UAS-EGFR.DN}/p{tinC-Gal4} maintained at 25uC then shifted to 18uC for 144 hours. Data for EGFR
f24/
tsla (n=7)
and p{UAS-EGFR.DN}/p{tubulin-Gal80
ts}; p{UAS-EGFR.DN}/p{tinC-Gal4} (n=15) experiments was obtained by serial OCT measurements in individual
flies. The cardiac chamber sizes in p{tubulin-Gal80
ts}/+; p{tinC-Gal4}/+ that did not harbor a UAS-EGFR.DN transgene were used as controls and
examined at 18uC and 25uC. *p,0.05 for EGFR
f24/tsla at 25uC versus 18uC baseline. #p,0.05 for p{UAS-EGFR.DN}/p{tubulin-Gal80
ts}; p{UAS-EGFR.DN}/
p{tinC-Gal4} at 25uC for 96 or 144 hours versus 18uC baseline; Dp,0.05 for p{UAS-EGFR.DN}/p{tubulin-Gal80
ts}; p{UAS-EGFR.DN}/p{tinC-Gal4} at 18uC
for 144 hours versus 25uC baseline. Closed circles represent individual measurements for each group, open circles represent the mean 6 SEM for each
group.
doi:10.1371/journal.pgen.1000969.g006
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suggests that proper EGFR signaling is required for the
maintenance of normal adult heart function.
Discussion
Our results suggest that rho3-mediated EGFR signaling is
responsible for the enlarged cardiac phenotype observed in
Df(3L)ED4238/+. Several lines of evidence support a role for
rho3 in adult cardiac function. Analyses of the cardiac phenotypes
in mutants that have ru
1 or rho3
pLLB alleles are consistent with
previously described effects in other tissues including the fly eye
[13]. The ru
1 allele acts as a hypomorphic allele since homozygote
ru
1, but not heterozygote ru
1, mutants have an enlarged cardiac
chamber. However, homozygote and heterozygote rho3
pLLB
mutants have enlarged cardiac chambers consistent with the
rho3
pLLB allele acting as a null allele. The ru
1 allele encodes a
premature stop codon however a truncated protein product was
not detected and therefore the mechanism underlying the
hypomorphic nature of the ru
1 allele is not clear. Possible
explanations include a dosage effect such that a reduction in
functional rho3 transcript/product to below a certain threshold
results in a phenotype.
Prior work has demonstrated that rho3 interacts with rho1 and
these proteases act together in cell signaling processes [14].
Although our results suggest that rho3 is important in the adult
Drosophila heart, we recognize that rho1 and rho2 may also
contribute to the complex signals that influence post-developmen-
tal cardiac function. Interestingly, Df(3L)Exel6087/+ that was
heterozygote for a deficiency across the rho1 and rho2 loci but did
not disrupt rho3 had normal cardiac function. Additionally, ru
1/+,
rho
7M43/+ flies that were heterozygous for the ru
1 allele and an
amorphic allele of rho1 also did not appear to have an enlarged
cardiac chamber. QRT-PCR data also showed that rho1 mRNA
levels were not significantly different in deficiency lines,
Df(3L)ED4238/+ or d07829-f07223/+, that had an abnormal
cardiac chamber size. Although the abnormal cardiac phenotype
observed in strains that have heterozygote deficiencies in rho3 or
homozygous ru
1 mutants was rescued by tinC-mediated expression
of recombinant rho3, we recognize that over-expression of rho3
may compensate for abnormalities in rho1 function and therefore
obfuscate the importance of rho1 in adult cardiac function.
Our results also demonstrated that normal cardiac chamber size
was restored in Df(3L)ED4238/+ and homozygous ru
1 by cardiac-
specific expression of components downstream of rho3 including
Spitz and EGFR. The restoration of cardiac function by
transgenic expression of EGFR can be explained by two possible
processes. First, the over-expression of EGFR monomers may
increase the probability ligand-independent dimerization of EGFR
resulting in potentially higher basal EGFR signaling and a rescue
of cardiac function [10,45]. Second, an unknown EGFR ligand
other that Spitz may be responsible for restoration of cardiac
function. Other EGFR ligands, including Keren and Gurkin, have
been described to activate EGFR in specific tissues including the
eye and ovary [39,46–48]. Our results demonstrate that mutants
with a null allele for Keren do not have an abnormal cardiac
function although Keren was reported to function similarly to
Spitz in eye development. However, other Spitz-like ligands may
interact with cardiac EGFR and explain the observation that
cardiac chamber size is normal in the presence of cardiac-specific
EGFR transgene expression in the context of impaired rho3
function. Additionally, the rescue of the abnormal cardiac
phenotype by tinC-Gal4 mediated transgenic expression of rho3
itself or active soluble Spitz suggests that these signals function in
an autocrine manner or between the cardiomyocytes that
comprise the cardiac tube.
Despite the functional abnormality observed by OCT in adult
ru
1 homozygous mutants, we observed that the embryonic dorsal
vessel and pupal heart morphology in ru
1 homozygotes did not
differ from w
1118. The adult homozygous ru
1 mutants had similar
extra cardiac structures and dorsal diaphragm muscle fibers
compared to w
1118. Furthermore, the actin fiber organization did
not appear obviously different from w
1118 although the heart
chamber wall appeared thinner as compared to w
1118. These
findings are strikingly different from other fly mutants that have
enlarged cardiac chambers [5,31,49]. For example, hdp
2, a fly that
has a recessive point mutation in troponin-I, has a markedly
enlarged heart with poor systolic function and has abnormalities in
the organization of contractile elements. Additionally, flies that
have deficiencies in dystrophin also demonstrate poor contractile
function, enlarged cardiac chambers, and myofibrillar disorgani-
zation [31]. Our findings suggest that additional mechanisms may
exist that responsible for an enlargement in the Drosophila heart
and are not associated with dramatic abnormalities in myofibrillar
organization or cardiomyocyte cell number. While the exact
mechanisms through which alterations in rhomboid signaling
translate into functional myocardial impairment remain to be
elucidated, our results support that further studies of the
downstream signaling components of EGFR are necessary.
The post-developmental expression of a dominant-negative
EGFR under the control of the temperature-sensitive Gal80
system resulted in a progressive deterioration in cardiac function.
These results suggest that rho3-EGFR signaling maintains adult
cardiac function. Additionally, the developing cardiac system in
Drosophila appears to be sensitive to the level of EGFR activation
since tinC-mediated expression of constitutively-active EGFR
transgenes resulted in the failure of flies to eclose from pupal cases.
We also observed the rescue of cardiac chamber size and function
post-developmentally when EGFR-DN was repressed in adult flies
after the development of an enlarged heart. The findings suggest
that the adult fly heart has a degree of plasticity such that the
removal of a deleterious cardiac perturbation may restore normal
heart camber size and function. This is quite different from most
cardiomyopathies in mammals in which a defect in cardiac
function often leads to a progressive and irreversible deterioration
of the heart. The mechanisms underlying the plasticity of the adult
fly heart and the exact downstream components of EGFR
signaling that are responsible for maintaining adult cardiac
function will require further investigation.
The identification of EGFR signaling in adult Drosophila heart
function underscores the concept that evolutionarily conserved
signaling mechanisms are required to maintain normal myocardial
function. In mammals the EGF receptor is one member of the
larger ErbB receptor family. Recently, Alvarado et al. had shown
that human ErbB2 is the closest structural relative to Drosophila
EGFR and suggest that ErbB2 shares more similarities with
invertebrate EGFR than other isoforms of other human ErbB
members [50]. ErbB2 is a target of chemotherapy in the treatment
of several cancers and the inhibition of ErbB2 signaling by
transgenic knock-out in mice and herceptin-treatment humans is
associated with the development of dilated cardiomyopathy [51–
53]. Our findings support that EGFR signaling is required for
cardiac function in Drosophila. Furthermore, our results in
conjunction with the demonstration that altered ErbB2 signaling
underlies certain forms of mammalian cardiomyopathy suggest
that an evolutionarily conserved signaling mechanism may be
necessary to maintain post-developmental cardiac function.
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out the animal kingdom including mammals [54]. Although
rhomboids do not appear be involved in EGF signaling in
mammals, prior work has identified ephrin B and thrombomodu-
lin as potential substrates of rhomboids [55,56]. Our results
demonstrate a new role for rhomboid proteases in post-
developmental adult Drosophila cardiac function and suggest that
further investigations may provide insight into potential mecha-
nisms of mammalian rhomboid proteases in human dilated
cardiomyopathies and heart failure.
Our observations also support an important concept that
underlies our screening strategy. Namely, a screen for altered
cardiac chamber dimensions and function in adult flies based on
functional phenotyping can identify mutations that do not
significantly alter the morphology of the dorsal vessel in the
embryo. We acknowledge that the consequences of cardiac
dysfunction in the fly are not the same as in humans; however,
aspects of cardiac abnormalities are shared at some level and may
help identify pathways that potentially affect human disease. While
this concept may be simple, our observations support the rationale
of our ongoing screens to identify genes that cause cardiac
abnormalities in adult Drosophila.
Materials and Methods
Materials
DrosDel and Exelixis stocks as well as all mutants were obtained
from the Bloomington Drosophila Stock Center unless otherwise
stated below. All stocks were maintained on standard yeast protein
media at room temperature. The p{tinC-Gal4} was kindly proved
by Manfred Frasch [22]. The p{UAS-sSpi} and p{UAS-mSpi}
stocks were kindly provided by Andreas Bergmann and Hermann
Steller [10,36]. The p{tubulin-Gal80
ts}; p{tinC-Gal4} stocks were
engineered based on methods described by McGuire et. al. [42].
rho-3
PLLb, spi-SCP2, rho-4, rho-6, and the double rho-4;rho-6 mutants
were kindly provided by Matthew Freeman [13]. The Keren
exc 27-7-B
mutant was kindly provided by Denise Montell [39].
Generation of specific genomic deficiencies
Drosophila containing specific P-element insertions designated
P{XP}Ptp61F
d01050, PBac{WH}Ptp61F
f07223, P{XP}Ptp61F
d07829,
and PBac{WH}msd5
f05423 were obtained from the Exelixis Collection
at Harvard Medical School. Specific genomic deficiencies were
generated using P{hsFLP}1, y[1] w[1118]; Dr[Mio]/TM3, ry[*]
Sb[1] according to the established methods [6]. The genomic
deficiencies were genotyped using iPCR methods and DNA
sequencing as described by Parks et. al. [6].
OCT measurement of cardiac function in adult Drosophila
Cardiac function in adult Drosophila was measured using a
custom built OCT microscopy system (Bioptigen, Inc. Durham,
NC) as previously described [5]. Flies that had genomic
deficiencies from the Exelixis or DrosDel collections were bred
with w
1118 to remove balancer chromosomes and the F1
generation was used to examine cardiac parameters. Additionally,
all stocks that had alleles maintained over a balancer chromosomes
were bred to w
1118 to remove the balancer chromosome prior to
evaluation of the cardiac parameters in the F1 offspring.
Briefly, adult female Drosophila between 7 and 10 days post
eclosion were briefly subjected to CO2, placed on a soft gel
support, and allowed to fully awaken based on body movement.
All flies were imaged as B-modes in the longitudinal orientation to
identify the cardiac chamber in the A1 segment and then in the
transverse orientation to center the heart chamber. Multiple 3
second OCT m-modes were recorded and images were processed
using ImageJ software using a 125 micron standard. After m-mode
acquisition, the flies were examined in the transverse B-mode
orientation to assure consistent measurements from the heart
chamber. End-diastolic (EDD), end-systolic (ESD), and heart rate
were determined from 3 consecutive heart beats. Fractional
shortening (FS) was calculated as [EDD-ESD]/EDD 6100. OCT
measurements were binned into 8 micron cut-off values based on
the axial resolution of the OCT instrument. Each OCT
measurement is represented in the graphs as a closed circle to
provide an estimate of the frequency observed for each
measurement in the corresponding groups for the experiments
described in the text. A summary of the OCT data for each group
represented by an open circle and corresponds to the mean +/-
SE. Since the resolution of OCT is limited to 8 microns, we also
analyzed the data in a dichotomized manner where we defined an
‘‘enlarged’’ heart as an EDD .90 microns and ‘‘impaired systolic
function’’ as an ESD .20 microns.
For serial OCT studies, adult flies were bred at 18uC until 7 to
10 days post eclosion prior to initial evaluation of cardiac function
by OCT. After each OCT measurement, individual files were
gently removed from the soft gel and placed in individual vials at
25uC with food. Serial evaluation of cardiac function by OCT was
conducted as described in the figures.
QRT-PCR
Total RNA samples from ten female flies of 7 days post-eclosion
were prepared from w
1118, Df(3L)ED4328/+, heterozygous
genomic deficiencies d07829-f07223/+ or f05432-d01050/+, ru
1
homozygous mutants (ru
1/ru
1), rho3
pLLB heterozygotes (rho3
pLLB/+),
or rho3
pLLB homozygotes (rho3
pLLB/rho3
pLLB) using RNA-Bee (Tel-
Test ‘‘B’’). Embryos, larvae, pupae, and dissected adult tissues
were collected from w
1118 to define the transcriptional expression
pattern of rho1 and rho3. Two mg of RNA was used for generation
of cDNA using SuperScript II reverse transcriptase (Invitrogen,
Inc.). Applied Biosystems Taqman Gene expression assays were
used to perform quantitative (real time) RT-PCR (rho3:
Dm01837284_m1; rho1: Dm01821932_m1, and Ribosomal
Protein L32 (Rpl32): Dm 02151827-g1 for endogenous control).
The following reaction components were used for each probe:
2 mL cDNA, 12.5 ml 2X TaqMan Universal PCRMaster Mix
without Amperase (Applied Biosystems, Inc.), 1.25 ml of probe,
and 9.25 ml water in a 25 ml total volume. Reactions were
amplified and analyzed in triplicate using an ABI PRISMH 7000
Sequence Detection System. PCR reaction conditions were as
follows: Step 1: 95uC for 10 minutes, Step 2: 40 cycles of 95uC for
15 seconds followed by 60uC for 1 minute. Expression relative to
Rpl32 was calculated using 2
2DDCt and levels were normalized to
baseline. We performed three independent experiments in
triplicate using different batches of flies each time.
Transgenic wt-rho3 and tinC-GFP lines
The cDNA encoding wt-rho3 was isolated by RT-PCR from
w
1118 adult flies, subcloned into pUAST, and verified by
sequencing. Transgenic Drosophila harboring wt-rho3 were gener-
ated by established methods [57]. The tinC-GFP Drosophila lines
were created by isolating and subcloning the 304 bp tinC genomic
sequence from w
1118 into pGreen-H-Pelican [22,58].
Expression of rho3 cDNA in S2 cells
S2 cells were maintained in Schneider’s media containing 10%
fetal bovine serum under standard conditions. Total RNA was
isolated from adult w
1118, Oregon-R, and homozygous ru
1 mutant
flies using RNAzole-Bee (Tel-Test ‘‘B’’) and then used to obtain
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d(T)16 primers. Next, rho3 cDNA was isolated by PCR with
primers corresponding to the 59 and 39 ends of rho3 and Platinum-
Taq (Invitrogen Inc.). The PCR products were subcloned into
pUAST with 59 primers containing flag-tag epitopes. DNA
sequencing was performed at multiple steps throughout the
subcloning steps.
S2 cells were transfected with 1 mg of pUAST alone or pUAST
containing N-terminally flag-tagged rho3 cloned from w
1118,
Oregon-R, and ru
1 mutant flies, respectively, in the presence of 1 ug
of pPTGAL plasmid encoding Gal4 driven by an ubiquitin
promoter (gift from H. Amerin) using Cellfectin reagent (Invitro-
gen, Inc.). After 48 hours of incubation, the cells were washed
gently in PBS, lysed in 500 ml of RIPA buffer, placed on ice for 20
minutes, and then subjected to centrifugation at 12,0006g for 15
minutes. Total protein content in each lysate was determined
using a Bio-Rad protein assay. 20 mg of total protein was applied
to 12% polyacrylamide denaturing gels and proteins were resolved
by electrophoresis prior to Immunoblotting. The mouse mono-
clonal anti-flag M2 antibody (1:2000) (Sigma, Inc.) was used to
detect Flag-fusion proteins.
Evaluation of adult cardiac morphology
Adult Drosophila corresponding to homozygous tinC-GFP in
w
1118 background alone or in the presence of homozygous ru
1 at 7
days age post eclosion were used to examine adult cardiac
morphology. Flies were briefly anesthetized by administration of
CO2, the head and thorax were removed and the abdomen was
placed in artificial hemolymph buffer (108 mM Na
+, 5 mM K
+,2
mM Ca
2+, 8 mM MgCl2, 1 mM NaH2PO4, 4 mM NaHCO3,1 0
mM sucrose, 5 mM trehalose, and 5 mM Hepes (pH 7.1) [59]. An
incision was made along the ventral aspect of the abdomen and
the internal abdominal organs were gently removed. The
surrounding fat and tissue was removed using a pulled glass
capillary pipette. Then hemolymph buffer that contained 10mM
EGTA was added to relax the cardiac muscle as described by
Alayari et. al. [60]. Next, samples were fixed in 4% paraformal-
dehyde for 20 minutes at room temperature prior to staining with
anti-GFP-antibody (1:500) (Invitrogen, Inc.) for detection of
cardiomyocytes and phalloidin-TexasRed (1:1,000) (Invitrogen,
Inc.) for actin staining. The stained heart preparations were
visualized under a Zeiss LSM510 confocal microscope and 0.4
micron Z-stack images were analyzed.
For evaluation of cardiac morphology during pupal stages,
Drosophila corresponding to homozygous tinC-GFP in w
1118
background or in the presence of homozygous ru
1 were collected
between the ,P6 and P13 stages according to staging described by
Bainbridge and Bownes [61]. Pupal hearts were directly visualized
using a Leica M165FC fluorescent stereomicroscope.
For heart rate measurements, whole flies corresponding to
homozygous tinC-GFP in w
1118 background or in the presence of
homozygous ru
1were examined intact or after dissection as
described above and the hearts were visualized using a Leica
M165FC fluorescent stereomicroscope equipped with a
DFC310Fx camera. Images were captures at a frame rate of
,38 fps for analysis.
Histological analysis
Adult female flies of 7 to 10 days age were collected, immersed
in 70% alcohol for 1 minute, and then fixed in 10% buffered
formalin overnight at 4uC. Next, the specimens were rinsed in PBS
and dehydrated in ethanol through sequential gradients. Then, the
samples were washed twice with xylenes before immersion in
liquid paraffin. After solidification, paraffin blocks were sectioned
serially at 8 mm thickness in longitudinal or transverse orientation
(n=8 flies per orientation per group). Sections were rehydrated
and stained with hematoxylin and eosin. The following criteria
were used to control for the position of the heart chamber among
different flies that were evaluated. First, we identified the
transverse section with that contained the en face view of the
ventral longitudinal fibers (VLF) corresponding to the anterior
conical chamber. Second, we counted three serial 8 micron
sections posterior from the section with the en face view of the VLF.
Third, we measured the chamber dimension in the next three
serial 8 micron sections (denoted MS1, MS2, and MS3 in Figure
S4). Sections were analyzed using an Olympus 1X70 microscope
at 4006 magnification and images captured using a PaxCam
digital camera. We measured the diameter of the cardiac chamber
in the dorsal to ventral direction in transverse oriented sections
since this measurement corresponded to the orientation of the
measurements obtained by OCT. Wall thickness was calculated by
measuring the cardiac chamber wall width along the lateral walls
at two positions in three serial sections to obtain the mean 6 SEM.
To determine the degree that fixation may have had on
chamber size, we examined the chamber size in flies that were
fixed after the 70% alcohol step by performing measurements
using OCT. The cardiac chamber sizes in fixed flies were similar
to the EDD in awake, adult flies.
Statistical analysis
Comparisons of EDD chamber dimensions were determined by
either a student’s t-test for two samples or an analysis of variances
(ANOVA) with Bonferroni corrections for multiple comparisons
when necessary. Comparisons of ESD chamber dimensions were
determined by Mann-Whitney tests for comparisons of two
samples or Kruskal-Wallis tests with a Dunn’s test for multiple
comparisons. GraphPad Prism statistical software (GraphPad
Software Inc.) was used for all analyses.
Supporting Information
Figure S1 Fractional Shortening measurements in adult Dro-
sophila as determined by OCT. (A) Summary data of cardiac
measurements for Fractional Shortening (FS) from w
1118,
Df(3L)ED4238/+, and hdp
2.n = 1 3 217 flies per group. *p,0.05
for the indicated measurements compared to w
1118 using an
ANOVA with Bonferroni correction. (B) Summary data of cardiac
measurements for FS from w
1118, ru
1 homozygotes (designated ru
1/
ru
1), ru
1 heterozygotes (ru
1/+), rho3
pLLB heterozygotes (rho3
pLLB/+),
and rho3
pLLB homozygotes (rho3
pLLB/rho3
pLLB). n=8217 flies per
group. *p,0.05 for the indicated measurements by ANOVA with
Bonferroni correction for multiple comparisons. (C) Summary
data of cardiac measurements for FS from w
1118, homozygous ru
1
mutants (ru
1/ru
1), Df(3L)ED4238/+, and transgenic flies harboring
the driver tinC-Gal4 and UAS-wt-rho3, UAS-mSpi, UAS-sSpi, or
UAS-EGFR in the context of the Df(3L)ED4238/+ or the
homozygous ru
1 mutant. n=8217 flies per group. *p,0.05 for
the indicated measurements comparing Df(3L)ED4238/+ alone
versus Df(3L)ED4238/+ expressing the indicated transgenes or
homozygous ru
1 alone versus homozygous ru
1 in the context of the
indicated transgenes. FS measurements were analyzed by student’s
t-test. (D) Summary OCT data for FS for EGFR
f24/tsla maintained
at 18uC and after 24 hours at 25uC and p{UAS-EGFR.DN}/
p{tubulin-Gal80
ts}; p{UAS-EGFR.DN}/p{tinC-Gal4} main-
tained at 18uC followed by 24 hour, 96 hours, and 144 hours at
25uC. The summary also shows data for the reversal of the cardiac
phenotype for p{UAS-EGFR.DN}/p{tubulin-Gal80
ts}; p{UAS-
EGFR.DN}/p{tinC-Gal4} maintained at 25uC then shifted to
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f24/
tsla (n=7) and p{UAS-
EGFR.DN}/p{tubulin-Gal80
ts}; p{UAS-EGFR.DN}/p{tinC-
Gal4} (n=15) experiments was obtained by serial OCT
measurements in individual flies. The fractional shortening in
p{tubulin-Gal80
ts}/+; p{tinC-Gal4}/+ that did not harbor a
UAS-EGFR.DN transgene were used as controls and examined at
18uC and 25uC. *p,0.05 for EGFR
f24/tsla at 25uC versus 18uC
baseline. #p,0.05 for p{UAS-EGFR.DN}/p{tubulin-Gal80
ts};
p{UAS-EGFR.DN}/p{tinC-Gal4} at 25uC for 96 or 144 hours
versus 18uC baseline; Dp,0.05 for p{UAS-EGFR.DN}/
p{tubulin-Gal80
ts}; p{UAS-EGFR.DN}/p{tinC-Gal4} at 18uC
for 144 hours versus 25uC baseline. Closed circles represent
individual measurements for each group and open circles
represent the mean 6 SEM for each group.
Found at: doi:10.1371/journal.pgen.1000969.s001 (0.65 MB TIF)
Figure S2 The mutant ru
1 encodes a missense mutation. (A)
Representative DNA sequencing chromatograms for rho3 from
w
1118 and ru
1 showing that ru
1 has a premature stop codon at
nucleotide position 163 corresponding to amino acid position 55.
A schematic of the gene structure is shown below with coding
exons #4 and 5 (gray boxes) and introns (black line). The asterisk
represents the position of the mutation in ru
1. (B) Immunoblot of
20 ug total protein lysate from S2 cells expressing N-terminal Flag-
tagged rho3 corresponding to cDNAs from w
1118, Oregon-R, and
ru
1 flies. Each construct was expressed from 1 ug of corresponding
pUAST constructs co-transfected in S2 cells with 1 ug of a
pPTGAL plasmid encoding Gal4 driven by an ubiquitin
promoter. rho3 protein produce is denoted by the arrow and the
asterisk denotes a non-specific protein band. Protein markers in
kDa are shown on left.
Found at: doi:10.1371/journal.pgen.1000969.s002 (0.58 MB TIF)
Figure S3 Cardiac morphology in w
1118 and homozygous ru
1
mutants during the pupal stage. Panels are representative of hearts
from transgenic Drosophila that express tinC-GFP in the context of
w
1118 (A–C) or homozygous ru
1 mutants (D–E). (A,D) represent
,P6, (B,E) represent ,P8, and (C,F) represent ,P13 pupae based
on staging described by Bainbridge and Bownes [61]. The inset
below each panel shows a magnified view of the tinC-GFP positive
heart. The A1, A2, A3, and A4 segments are denoted in each
panel and the A5 segment could not be visualized. N=45 for
w
1118 pupae and N=47 for homozygous ru
1 mutant pupae for
each group.
Found at: doi:10.1371/journal.pgen.1000969.s003 (7.64 MB TIF)
Figure S4 Morphology of the adult heart in homozygous ru
1
mutants. (A) Schematic representation of an adult Drosophila heart
in the longitudinal orientation showing the region corresponding
to serial 8 microns sections for histological analyses. The transverse
section showing the cardiac chamber (CC) and the en face view of
the ventral longitudinal fibers (VLF) was used to orient the heart
position among the flies analyzed. The cardiac chamber size from
the mid dorsal to ventral wall was measured in three serial sections
(MS1, MS2, and MS3) to obtain the mean 6 SEM. The red box
indicated the approximate region of the cardiac chamber that was
evaluated in the corresponding transverse sections. (B) Represen-
tative H&E stained sections in the longitudinal (top) and transverse
orientation (bottom) through the adult cardiac chamber in w
1118
and homozygous ru
1 mutants (ru
1/ru
1). (n= 8 per group). A 125
micron standard is shown. (C) Summary data for cardiac chamber
size and cardiac wall thickness for w
1118 and homozygous ru
1
mutants (ru
1/ru
1) (n=8 flies analyzed for each group). The cardiac
chamber size was measured along the vertical axis from the mid
dorsal to mid ventral walls and the wall thickness was measured
from the mid lateral walls in sections corresponding to MS1, MS2,
and MS3 in (A). The values are expressed as the mean 6 SEM in
microns. *p,0.05 for chamber size or wall thickness analyzed by
students t-tests.
Found at: doi:10.1371/journal.pgen.1000969.s004 (3.32 MB TIF)
Figure S5 Heart rates in w
1118 and homozygous ru
1 mutants are
similar. The heart rates were measured at one day or seven to
fourteen days after eclosion in intact flies that expressed GFP
driven by tinC in the context of control (w
1118) or homozygous ru
1
alleles. Heart rates were also measured in dissected specimens
perfused in artificial hemolymph at seven days after eclosion. n=
4211 individual flies.
Found at: doi:10.1371/journal.pgen.1000969.s005 (0.40 MB TIF)
Table S1 Cardiac parameters from the initial screen of genomic
deficiencies along Drosophila Chromosome 3L. The data represent
the cardiac measurements in adult flies obtained by OCT for end-
diastolic dimension (EDD) in microns, end-systolic dimension
(ESD) in microns, and fractional shortening (FS). FS was
calculated as (EDD-ESD)/EDD x 100. Values are expressed as
the mean +/- SE. N=14216 samples per group. Additionally, the
data is represented in a binary manner with ‘‘Dilated’’ defined as
an EDD . 90 microns and ‘‘Impaired Systolic Function’’ defined
as an ESD . 20 microns) where ‘‘N’’ =no and ‘‘Y’’=yes.
Found at: doi:10.1371/journal.pgen.1000969.s006 (0.07 MB
DOC)
Table S2 Expression of rho1 and rho3 mRNA in different
developmental stages and adult tissues. Representative quantita-
tive real-time RT-PCR. Total RNA and cDNA were prepared
from embryos in indicated time points after birth, larvae, pupae,
and dissected adult tissues of w
1118. Summary data show relative
gene expression of rho3 and rho1 at developmental stages and in
adult tissues (expressed as fold-change compared to the rho3 or rho1
expression level at 0–8h embryo, respectively). Data represent
mean 6 SE of at least three independent experiments, each
performed in triplicate.
Found at: doi:10.1371/journal.pgen.1000969.s007 (0.03 MB
DOC)
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